Patient Characteristics
| Characteristic | Data |
|---|---|
| No. of patients | 74 |
| Median age (y) | 65 (IQR, 60–69) |
| Median PSA (ng/mL) | 11.1 (IQR, 7.5–21.5) |
| Initial PSA (ng/mL) | |
| <10 | 29 (39%) |
| 10–20 | 26 (35%) |
| >20 | 19 (26%) |
| D’Amico risk classification | |
| Intermediate risk | 14 (19%) |
| High risk | 60 (81%) |
| Presurgical Gleason grade | |
| 3 + 3 = 6 | 1 (1%) |
| 3 + 4 = 7 | 14 (20%) |
| 3 + 5 = 8 | 2 (2%) |
| 4 + 3 = 7 | 13 (19%) |
| 4 + 4 = 8 | 24 (34%) |
| 4 + 5 = 9 | 19 (27%) |
| 5 + 4 = 9 | 1 (1%) |
IQR = interquartile range; PSA = prostate-specific antigen level.